Breaking News Instant updates and real-time market news.

BHVN

Biohaven Pharmaceutical

$28.85

0.43 (1.51%)

04:55
01/05/18
01/05
04:55
01/05/18
04:55

Biohaven Pharmaceutical management to meet with William Blair

Meetings to be held in Chicago on January 4 and in Denver on January 5 hosted by William Blair.

  • 05

    Jan

BHVN Biohaven Pharmaceutical
$28.85

0.43 (1.51%)

10/03/17
NEED
10/03/17
NO CHANGE
NEED
Biohaven Pharmaceutical price target lowered to $36 from $43 at Needham
Needham analyst Alan Carr cut his price target on Biohaven after the company's trigriluzole drug missed its primary endpoint in a Phase 2/3 trial. The analyst removed the drug from his model but remains upbeat on the outlook for the Phase 3 trial of the company's trigriluzole drug, whose data is due out in 1Q18. He keeps a Buy rating on the shares.
12/11/17
PIPR
12/11/17
NO CHANGE
Target $48
PIPR
Overweight
Piper defends Biohaven shares after management meeting
Piper Jaffray analyst Charles Duncan says he's defending Biohaven Pharmaceutical shares after meeting with the company's management. The analyst has "reaffirmed conviction" on the company's clinical progress in 2018 and believes three sources of market inefficiency will be addressed in the near-term. First, he believes the migraine market opportunity for rimegepant is greater than $1B. Second, Duncan sees rimegepant as relatively risk-reduced and does not expect a signal to emerge in its long-term studies. Third, the analyst thinks the glutamate platform will become a value driver yet again during 2018. He reiterates an Overweight rating on Biohaven with a $48 price target.
12/15/17
ADAM
12/15/17
INITIATION
Target $30
ADAM
Buy
Biohaven Pharmaceutical initiated with a Buy at Canaccord
Canaccord initiated Biohaven Pharmaceutical with a Buy and $30 price target.
12/18/17
MSCO
12/18/17
NO CHANGE
MSCO
Morgan Stanley sees opportunities in biotech amid 'limited' investor conviction
With clinical catalysts in large-cap Biotechnology limited to only five key Phase III readouts - three of which are from Alexion (ALXN) - investors are describing their 2018 picks in the space as the "least worst" of the group, according to Morgan Stanley analyst Matthew Harrison. However, he believes this lack of conviction creates real opportunity for outsized moves in 2018, with Amgen (AMGN) identified by Harrison as the biggest potential beneficiary of M&A given "its likely newfound access" to about $39B in offshore cash. Other biotech names the analyst highlights on the up side include Biogen (BIIB), BioMarin (BMRN), Biohaven (BHVN) and Sarepta (SRPT). Meanwhile, Harrison highlights his concerns about potential downside for BioVerativ (BIVV) and Innoviva (INVA), on both of which he keeps Underweight ratings.

TODAY'S FREE FLY STORIES

TWTR

Twitter

$29.24

-1.24 (-4.07%)

14:05
04/25/18
04/25
14:05
04/25/18
14:05
Upgrade
Twitter rating change  »

Twitter upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    May

  • 27

    Jul

TMUS

T-Mobile

$63.95

1.37 (2.19%)

14:05
04/25/18
04/25
14:05
04/25/18
14:05
Options
T Mobile call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPKE

Spark Energy

$11.78

0.025 (0.21%)

14:04
04/25/18
04/25
14:04
04/25/18
14:04
Periodicals
Breaking Periodicals news story on Spark Energy »

Spark Energy said to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 10

    May

ACAD

Acadia

$19.95

0.47 (2.41%)

14:00
04/25/18
04/25
14:00
04/25/18
14:00
Periodicals
FDA head says will 'take another look' at Acadia's Nuplazid, CNN reports »

In response to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$304.83

-2.41 (-0.78%)

13:58
04/25/18
04/25
13:58
04/25/18
13:58
Conference/Events
Netflix management to meet with UBS »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

MSFT

Microsoft

$92.23

-0.85 (-0.91%)

13:55
04/25/18
04/25
13:55
04/25/18
13:55
Conference/Events
House Appropriations Committee to hold a hearing »

The Labor, Health &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

ZOOM

Zoom Technologies

13:55
04/25/18
04/25
13:55
04/25/18
13:55
Conference/Events
Zoom Technologies participates in a conference call with RBC Capital »

RBC Capital Software…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

JD

JD.com

$35.84

-0.03 (-0.08%)

13:50
04/25/18
04/25
13:50
04/25/18
13:50
Options
Volatility play in JD as January puts trade in large blocks Wednesday »

Volatility play in JD as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:50
04/25/18
04/25
13:50
04/25/18
13:50
General news
Treasury Curve Action: steepeners resumed »

Treasury Curve Action:…

AMD

AMD

$9.69

-0.4 (-3.96%)

13:40
04/25/18
04/25
13:40
04/25/18
13:40
Options
Aggresive buyer lays out $2.2M for deep in the money Advanced Micro puts »

Aggresive buyer lays out…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 02

    May

AAPL

Apple

$164.70

1.83 (1.12%)

13:40
04/25/18
04/25
13:40
04/25/18
13:40
Conference/Events
President Trump to meet with Apple CEO Cook »

The meeting between…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 01

    May

WELL

Welltower

$49.86

-1.16 (-2.27%)

, QCP

Quality Care Properties

$21.35

0.55 (2.64%)

13:37
04/25/18
04/25
13:37
04/25/18
13:37
Periodicals
Promedica, Welltower offering $2B to aquire Quality Care Properties, Reuters says »

Promedica and Welltower…

WELL

Welltower

$49.86

-1.16 (-2.27%)

QCP

Quality Care Properties

$21.35

0.55 (2.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 03

    May

  • 04

    May

EBAY

eBay

$40.63

-0.55 (-1.34%)

13:36
04/25/18
04/25
13:36
04/25/18
13:36
Technical Analysis
Technical Earnings Preview: eBay in uptrend ahead of earnings »

The shares have been in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LC

LendingClub

$2.78

-0.485 (-14.85%)

13:36
04/25/18
04/25
13:36
04/25/18
13:36
Hot Stocks
LendingClub calls charges in FTC complaint 'legally and factually unwarranted' »

Following an inquiry that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

LC

LendingClub

$2.78

-0.485 (-14.85%)

13:36
04/25/18
04/25
13:36
04/25/18
13:36
Hot Stocks
Breaking Hot Stocks news story on LendingClub »

LendingClub calls charges…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

FB

Facebook

$160.15

0.49 (0.31%)

, GOOG

Alphabet

$1,021.04

1.58 (0.15%)

13:35
04/25/18
04/25
13:35
04/25/18
13:35
Periodicals
Facebook declines to testify at U.S. House hearing on social media, Reuters says »

A Facebook (FB) spokesman…

FB

Facebook

$160.15

0.49 (0.31%)

GOOG

Alphabet

$1,021.04

1.58 (0.15%)

GOOGL

Alphabet Class A

$1,023.95

0.97 (0.09%)

TWTR

Twitter

$28.98

-1.5 (-4.92%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 25

    Apr

  • 30

    May

  • 27

    Jul

HOG

Harley-Davidson

$41.88

-0.13 (-0.31%)

13:30
04/25/18
04/25
13:30
04/25/18
13:30
Options
Hefty spread opened in Harley Davidson options »

Hefty spread opened in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    May

TWTR

Twitter

$28.97

-1.51 (-4.95%)

13:29
04/25/18
04/25
13:29
04/25/18
13:29
Recommendations
Twitter analyst commentary  »

Twitter outlook looks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    May

  • 27

    Jul

XOM

Exxon Mobil

$78.56

0.21 (0.27%)

13:29
04/25/18
04/25
13:29
04/25/18
13:29
Hot Stocks
Exxon Mobil boosts Q2 dividend to 82c from 77c »

Exxon Mobil's board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

FB

Facebook

$160.04

0.38 (0.24%)

13:25
04/25/18
04/25
13:25
04/25/18
13:25
Technical Analysis
Technical Earnings Preview: Facebook in an active bearish pattern before news »

There is a bearish…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

MGM

MGM Resorts

$35.36

-0.16 (-0.45%)

13:25
04/25/18
04/25
13:25
04/25/18
13:25
Options
MGM Resorts call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

CBLK

Carbon Black

13:25
04/25/18
04/25
13:25
04/25/18
13:25
Conference/Events
Cowen software analyst to hold an analyst/industry conference call »

Infrastructure &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 04

    May

BA

Boeing

$338.10

9.1 (2.77%)

13:23
04/25/18
04/25
13:23
04/25/18
13:23
Upgrade
Boeing rating change  »

Boeing upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    May

13:20
04/25/18
04/25
13:20
04/25/18
13:20
General news
Treasury Action: the OK auction hasn't really registered on Treasury screens »

Treasury Action: the OK…

TER

Teradyne

$35.36

-6.14 (-14.80%)

, AAPL

Apple

$165.05

2.18 (1.34%)

13:18
04/25/18
04/25
13:18
04/25/18
13:18
Recommendations
Teradyne, Apple analyst commentary  »

Teradyne valuation…

TER

Teradyne

$35.36

-6.14 (-14.80%)

AAPL

Apple

$165.05

2.18 (1.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 25

    Apr

  • 01

    May

  • 16

    May

  • 30

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.